GO

Mirae Asset Healthcare Fund-Reg(G)

very highequitypharma & health care
42.30 -0.67(-1.55%) NAV as on 22 May 2026
7.88 % 1 M
14.89 % 1 Y
26.93 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.68

As on 30 Apr, 2026
age-icon Age :

7 yrs 10 m

Since 02 07 ,2018
exit_load Exit Load :

1%

aum AUM :

2,939.23 Crs

lock_in Lock-in :

1% on or before 1Y(365D), Nil after 1Y(365D)

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

6.9

Min_Investment Min. Investment :

SIP 99 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Vrijesh Kasera,Tanmay Mehta

LATEST ASSET & PORTFOLIO ALLOCATION

as on Apr 30 ,2026
Others 0.04 %
Equity 99.96 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.76 %
Divi's Laboratories Ltd.8.23 %
Glenmark Pharmaceuticals Ltd.7.12 %
JB Chemicals & Pharmaceuticals...6.39 %
Apollo Hospitals Enterprise Ltd.5.93 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs76.50
Hospital & Healthcare Services22.23
Chemicals1.11
Miscellaneous0.10
Business Support0.00
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)22.3820.1231.1436.5137.82
Net Assets(Rs Crores) (as on 31-Mar-2026) 1817.47 1513.40 2235.15 2667.40 2753.72
Scheme Returns(%)(Absolute)18.45-9.8954.7416.015.71
B'mark Returns(%)(Absolute)NANANANANA
Category Rank34/7569/7623/908/10213/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Mirae Asset Healthcare Fund-Reg(G)Very HighEquity42.30-0.67(-1.55%)NAV As on 22 May, 202602-Jul-2018Inception Date2,939.23AUM In Cr.14.89%1Y26.93%3Y14.69%5Y20.05%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.79-0.28(-0.67%)NAV As on 22 May, 202613-Jul-2018Inception Date6,668.95AUM In Cr.9.54%1Y28.96%3Y16.08%5Y19.95%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity466.26-4.38(-0.93%)NAV As on 22 May, 202614-Jul-1999Inception Date4,323.29AUM In Cr.11.27%1Y26.71%3Y15.78%5Y16.08%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity33.51-0.27(-0.80%)NAV As on 22 May, 202610-Jul-2019Inception Date900.87AUM In Cr.12.15%1Y25.53%3Y12.99%5Y19.24%Since Inception
LIC MF Healthcare Fund-Reg(G)Very HighEquity31.08-0.38(-1.21%)NAV As on 22 May, 202628-Feb-2019Inception Date84.53AUM In Cr.10.77%1Y24.62%3Y11.08%5Y16.97%Since Inception